Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Aurinia Pharmaceuticals Inc. (AUPH)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Dec-31-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 8-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-K |
| Assets |
| Cash and equivalents | 81.4 | 94.1 | 151.4 | 131.6 | 231.6 | 57.6 | 156.6 | 272.4 |
| Short-term investments | 350.9 | 389.6 | 389.4 | 8.8 | 446.9 | 228.8 | 191.7 | 150.4 |
| Inventories | 33.2 | 24.8 | 25.9 | 26.3 | 19.3 | 19.3 | 15.9 | 13.9 |
| Other current assets | -49.6 | -65.9 | -113.5 | 310.9 | -184.5 | 23.5 | 8.1 | -17.3 |
| Total current assets | 415.9 | 442.5 | 453.2 | 477.6 | 513.3 | 329.2 | 372.2 | 419.4 |
| Property, plant, and equipment, net | 3.7 | 3.7 | 4.2 | 4.3 | 4.4 | 4.6 | 4.8 | 4.8 |
| Intangibles | 5.7 | 6.4 | 7.3 | 7.9 | 8.4 | 8.9 | 9.9 | 9.3 |
| Other fixed assets | 1.5 | 13.3 | 12.4 | 11.8 | 11.8 | 11.8 | 11.9 | 0.2 |
| Total assets | 548.9 | 470.9 | 482.1 | 506.9 | 543.4 | 360.1 | 417.1 | 463.7 |
| |
| Accounts payable | 4.8 | 3.1 | | 3.3 | 3.9 | 3.3 | 2.2 | 2.6 |
| Accrued expenses | 14.1 | 20.2 | 12.4 | 9.6 | 18.5 | 14.5 | 5.8 | 11.4 |
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other current liabilities | 42.8 | 22.9 | 22.2 | 21.0 | 18.3 | 19.8 | 13.2 | 18.0 |
| Total current liabilities | 61.7 | 46.1 | 34.6 | 33.8 | 40.6 | 37.5 | 21.2 | 32.0 |
| Other liabilities | 94.9 | 19.3 | 23.8 | 24.9 | 23.6 | 24.4 | 25.7 | 23.9 |
| Total liabilities | 156.6 | 65.4 | 58.4 | 58.8 | 64.3 | 61.9 | 46.9 | 55.9 |
| |
| Shareholders' equity [+] | 392.3 | 405.4 | 423.8 | 448.1 | 479.1 | 298.2 | 370.2 | 407.8 |
| Paid-in capital | 98.8 | 85.5 | 74.0 | 64.7 | 59.0 | 54.6 | 43.9 | 39.4 |
| Retained earnings | -902.0 | -864.3 | -829.3 | -793.8 | -756.1 | -722.8 | -625.5 | -575.2 |
| Tangible shareholders' equity | 386.6 | 399.0 | 416.4 | 440.2 | 470.7 | 289.2 | 360.4 | 398.4 |
|